0001708138-20-000108.txt : 20201118
0001708138-20-000108.hdr.sgml : 20201118
20201118160215
ACCESSION NUMBER: 0001708138-20-000108
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201116
FILED AS OF DATE: 20201118
DATE AS OF CHANGE: 20201118
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MURPHY ANDREW J
CENTRAL INDEX KEY: 0001796226
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19034
FILM NUMBER: 201324894
MAIL ADDRESS:
STREET 1: REGENERON PHARMACEUTICALS, INC.
STREET 2: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0000872589
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 133444607
STATE OF INCORPORATION: NY
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
BUSINESS PHONE: 9148477000
MAIL ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
FORMER COMPANY:
FORMER CONFORMED NAME: REGENERON PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19930328
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2020-11-16
0
0000872589
REGENERON PHARMACEUTICALS, INC.
REGN
0001796226
MURPHY ANDREW J
777 OLD SAW MILL RIVER ROAD
TARRYTOWN
NY
10591
0
1
0
0
EVP Research
Common Stock
2020-11-16
4
M
0
13736
30.63
A
60872
D
Common Stock
2020-11-16
4
F
0
7108
561.39
D
53764
D
Common Stock
2020-11-17
4
S
0
743
536.68
D
53021
D
Common Stock
2020-11-17
4
S
0
229
537.38
D
52792
D
Common Stock
2020-11-17
4
S
0
591
538.37
D
52201
D
Common Stock
2020-11-17
4
S
0
42
539.87
D
52159
D
Common Stock
2020-11-17
4
S
0
1442
540.49
D
50717
D
Common Stock
2020-11-17
4
S
0
812
541.42
D
49905
D
Common Stock
2020-11-17
4
S
0
294
542.37
D
49611
D
Common Stock
2020-11-17
4
S
0
467
543.65
D
49144
D
Common Stock
2020-11-17
4
S
0
68
544.01
D
49076
D
Common Stock
2020-11-17
4
S
0
171
545.47
D
48905
D
Common Stock
2020-11-17
4
S
0
524
546.61
D
48381
D
Common Stock
2020-11-17
4
S
0
148
547.12
D
48233
D
Common Stock
2020-11-17
4
S
0
216
548.77
D
48017
D
Common Stock
2020-11-17
4
S
0
283
549.67
D
47734
D
Common Stock
2020-11-17
4
S
0
206
550.71
D
47528
D
Common Stock
2020-11-17
4
S
0
141
551.48
D
47387
D
Common Stock
2020-11-17
4
S
0
73
552.88
D
47314
D
Common Stock
2020-11-17
4
S
0
64
553.21
D
47250
D
Common Stock
2020-11-17
4
S
0
114
556.45
D
47136
D
Common Stock
4242
I
By 401(k) Plan
Non-Qualified Stock Option (right to buy)
30.63
2020-11-16
4
M
0
13736
0.0
D
2020-12-14
Common Stock
13736
0
D
Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
Represents volume-weighted average price of sales of 743 shares of Company stock on November 17, 2020 at prices ranging from $536.41 to $536.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 17, 2020 at each separate price.
Represents volume-weighted average price of sales of 229 shares of Company stock on November 17, 2020 at prices ranging from $537.15 to $537.86. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 17, 2020 at each separate price.
Represents volume-weighted average price of sales of 591 shares of Company stock on November 17, 2020 at prices ranging from $538.03 to $538.59. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 17, 2020 at each separate price.
Represents volume-weighted average price of sales of 42 shares of Company stock on November 17, 2020 at prices ranging from $539.50 to $539.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 17, 2020 at each separate price.
Represents volume-weighted average price of sales of 1,442 shares of Company stock on November 17, 2020 at prices ranging from $540.00 to $540.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 17, 2020 at each separate price.
Represents volume-weighted average price of sales of 812 shares of Company stock on November 17, 2020 at prices ranging from $541.01 to $541.91. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 17, 2020 at each separate price.
Represents volume-weighted average price of sales of 294 shares of Company stock on November 17, 2020 at prices ranging from $542.15 to $542.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 17, 2020 at each separate price.
Represents volume-weighted average price of sales of 467 shares of Company stock on November 17, 2020 at prices ranging from $543.07 to $543.91. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 17, 2020 at each separate price.
Represents volume-weighted average price of sales of 171 shares of Company stock on November 17, 2020 at prices ranging from $545.37 to $545.86. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 17, 2020 at each separate price.
Represents volume-weighted average price of sales of 524 shares of Company stock on November 17, 2020 at prices ranging from $546.08 to $546.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 17, 2020 at each separate price.
Represents volume-weighted average price of sales of 148 shares of Company stock on November 17, 2020 at prices ranging from $547.12 to $547.20. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 17, 2020 at each separate price.
Represents volume-weighted average price of sales of 216 shares of Company stock on November 17, 2020 at prices ranging from $548.47 to $548.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 17, 2020 at each separate price.
Represents volume-weighted average price of sales of 283 shares of Company stock on November 17, 2020 at prices ranging from $549.03 to $549.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 17, 2020 at each separate price.
Represents volume-weighted average price of sales of 206 shares of Company stock on November 17, 2020 at prices ranging from $550.52 to $550.84. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 17, 2020 at each separate price.
Represents volume-weighted average price of sales of 141 shares of Company stock on November 17, 2020 at prices ranging from $551.31 to $551.72. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 17, 2020 at each separate price.
Represents volume-weighted average price of sales of 114 shares of Company stock on November 17, 2020 at prices ranging from $556.38 to $556.46. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 17, 2020 at each separate price.
The stock option award vests in four equal annual installments, commencing one year after the date of grant.
/s/**Andrew Murphy
2020-11-18